Fractional exhaled nitric oxide and the peripheral blood eosinophil count as biomarkers of the response to mepolizumab in patients with severe eosinophilic asthma

Fractional exhaled nitric oxide and the peripheral blood eosinophil count as biomarkers of the response to mepolizumab in patients with severe eosinophilic asthma

Bibliografski detalji
Glavni autori:	Shrimanker, R, Pavord, I, Price, R, Bradford, E, Keene, O, Yancey, S
Format:	Conference item
Izdano:	American Thoracic Society 2018

Slični predmeti

Prognostic and predictive value of blood eosinophil count, fractional exhaled nitric oxide and their combination in severe asthma: a post-hoc analysis
od: Shrimanker, R, i dr.
Izdano: (2019)

Evaluation of potential continuation rules for mepolizumab treatment of severe eosinophilic asthma.
od: Gunsoy, N, i dr.
Izdano: (2017)

Efficacy of add-on mepolizumab in adolescents with severe eosinophilic asthma
od: Steven W. Yancey, i dr.
Izdano: (2019-09-01)

Clinical characterisation of exacerbations of severe eosinophilic asthma occurring on mepolizumab and placebo
od: Howell, I, i dr.
Izdano: (2024)

Oral glucocorticoid-sparing effect of mepolizumab in eosinophilic asthma.
od: Bel, E, i dr.
Izdano: (2014)

Mepolizumab treatment in patients with severe eosinophilic asthma.
od: Ortega, H, i dr.
Izdano: (2014)

Glucocorticoids and mepolizumab in eosinophilic asthma.
od: Bel, E, i dr.
Izdano: (2014)

Mepolizumab in refractory eosinophilic asthma.
od: Pavord, I, i dr.
Izdano: (2010)

Clinical characterisation of exacerbations of severe eosinophilic asthma occurring on mepolizumab and placebo
od: Imran Howell, i dr.
Izdano: (2024-07-01)

Mepolizumab for eosinophilic COPD
od: Sciurba, F, i dr.
Izdano: (2018)

Association of elevated fractional exhaled nitric oxide concentration and blood eosinophil count with severe asthma exacerbations
od: Price, D, i dr.
Izdano: (2019)

Meta-analysis of asthma-related hospitalization in mepolizumab studies of severe eosinophilic asthma
od: Yancey, S, i dr.
Izdano: (2016)

Diagnostic possibility of the combination of exhaled nitric oxide and blood eosinophil count for eosinophilic asthma
od: Jiang-Hua Li, i dr.
Izdano: (2021-08-01)

Association of elevated fractional exhaled nitric oxide concentration and blood eosinophil count with severe asthma exacerbations
od: David B. Price, i dr.
Izdano: (2019-08-01)

Mepolizumab, quality of life, and severe eosinophilic asthma.
od: Pavord, I
Izdano: (2017)

Severe eosinophilic asthma treated with mepolizumab stratified by baseline eosinophil thresholds: a secondary analysis of the DREAM and MENSA studies.
od: Ortega, H, i dr.
Izdano: (2016)

Mepolizumab and the response to oral prednisolone in patients with severe eosinophilic asthma
od: Shrimanker, R, i dr.
Izdano: (2017)

Mepolizumab and exacerbations of refractory eosinophilic asthma.
od: Haldar, P, i dr.
Izdano: (2009)

Biomarkers for severe eosinophilic asthma.
od: Yancey, S, i dr.
Izdano: (2017)

Blood eosinophil depletion with mepolizumab, benralizumab and prednisolone in eosinophilic asthma
od: Moran, AM, i dr.
Izdano: (2020)

Evaluation of sputum eosinophil count as a predictor of treatment response to mepolizumab
od: Ian D. Pavord, i dr.
Izdano: (2022-05-01)

Characterisation of exacerbations of severe eosinophilic asthma (SEA) on mepolizumab compared to placebo
od: Shrimanker, R, i dr.
Izdano: (2017)

Targeting the IL-5 pathway in eosinophilic asthma: a comparison of mepolizumab to benralizumab in the reduction of peripheral eosinophil counts
od: Arian Ghassemian, i dr.
Izdano: (2021-01-01)

The peripheral blood eosinophil count as a biomarker of eosinophilic airway inflammation in patients with asthma and COPD. Experience from a single centre
od: Shrimanker, R, i dr.
Izdano: (2017)

Mepolizumab for eosinophilic chronic obstructive pulmonary disease
od: Pavord, I, i dr.
Izdano: (2017)

Association between fractional exhaled nitric oxide, sputum induction and peripheral blood eosinophil in uncontrolled asthma
od: Jie Gao, i dr.
Izdano: (2018-05-01)

Efficacy and safety of mepolizumab in Japanese patients with severe eosinophilic asthma
od: Terufumi Shimoda, i dr.
Izdano: (2017-07-01)

Does a composite score combining peripheral blood eosinophils (PBE) and exhaled nitric oxide (FeNO) accurately predict a sputum eosinophilia?
od: Connolly, CM, i dr.
Izdano: (2017)

Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial.
od: Pavord, I, i dr.
Izdano: (2012)

Response to Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma and Atopic Phenotypes
od: Prazma CM, i dr.
Izdano: (2021-06-01)

Both fractional exhaled nitric oxide and sputum eosinophil were associated with uncontrolled asthma
od: Gao J, i dr.
Izdano: (2018-04-01)

Clinical usefulness of mepolizumab in severe eosinophilic asthma
od: Menzella F, i dr.
Izdano: (2016-06-01)

Late breaking abstract - Dose-ranging study of mepolizumab in eosinophilic COPD
od: Pavord, I, i dr.
Izdano: (2017)

Oral corticosteroid dose changes and impact on peripheral blood eosinophil counts in patients with severe eosinophilic asthma: a post hoc analysis
od: Charlene M. Prazma, i dr.
Izdano: (2019-05-01)

Blood eosinophil phenotype during treatment with mepolizumab in patients with severe eosinophilic asthma
od: Chio Sakai, i dr.
Izdano: (2024-07-01)

The use of exhaled nitric oxide concentration to identify eosinophilic airway inflammation: an observational study in adults with asthma.
od: Berry, M, i dr.
Izdano: (2005)

Mepolizumab or placebo for eosinophilic granulomatosis with polyangiitis
od: Wechsler, M, i dr.
Izdano: (2017)

Fractional exhaled nitric oxide and eosinophil count in induced sputum to guide the management of children with asthma: a cost-utility analysis
od: Buendía, JA, i dr.
Izdano: (2022)

Fractional exhaled nitric oxide and eosinophil count in induced sputum to guide the management of children with asthma: a cost-utility analysis
od: Jefferson Antonio Buendía, i dr.
Izdano: (2022-06-01)

Treatment Resistance in Severe Asthma Patients With a Combination of High Fraction of Exhaled Nitric Oxide and Low Blood Eosinophil Counts
od: Yuki Hoshino, i dr.
Izdano: (2022-04-01)